In patients who remain comatose after ROSC, actively prevent fever (≤ 37.5 °C) for at least 72 h. Hypothermia at 32-36 °C is acceptable but not proven better.
At the bedside
Timed steps- 1
Identify eligible patients
0-1 hAny adult not following commands after ROSC, regardless of rhythm or location.
- 2
Measure core temperature
0-1 hBladder, oesophageal or blood (PA/femoral catheter) probe. Avoid axillary readings.
- 3
Choose target
StartERC-ESICM: actively prevent fever, keeping temperature ≤ 37.5 °C. AHA: choose and maintain a constant temperature between 32 and 37.5 °C.
- 4
Devices
StartFeedback-controlled surface or intravascular device if available. Otherwise cold packs, cooling blankets, fans, paracetamol. No prehospital cold IV fluid boluses.
- 5
Sedation and shivering
ThroughoutShort-acting sedation (propofol, fentanyl/remifentanil); manage shivering (Bedside Shivering Assessment Scale) with skin counter-warming, magnesium, opioids, dexmedetomidine; neuromuscular block as last resort.
- 6
Duration
≥ 36-72 hAHA: ≥ 36 h; ERC-ESICM: prevent fever for at least 72 h.
- 7
Slow
RewarmingIf cooled below 36 °C: rewarm ≤ 0.25-0.5 °C/h; continue to prevent fever after rewarming. Do not actively rewarm patients with mild spontaneous hypothermia (32-36 °C) (ERC).
Key temperature trials
| Trial | Population | Comparison | Result |
|---|---|---|---|
| TTM1 (2013) | OHCA, all rhythms, n=950 | 33 vs 36 °C | No difference in mortality or neurological outcome |
| HYPERION (2019) | Non-shockable, OHCA and IHCA, n=584 | 33 °C vs 37 °C | Better neurological outcome at 90 days with 33 °C (10.2% vs 5.7%); fragile result |
| TTM2 (2021) | OHCA, n=1900 | 33 °C vs normothermia with fever prevention (≤ 37.8 °C) | No difference in 6-month mortality; more arrhythmias with hypothermia |
References
- 1
- 2
- 3
- 4
- 5
Temperature control pathway
Step 1 of ~7
Core temperature probe; sedation; arterial line
Based on Nolan JP, Sandroni C, Cariou A, et al; Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Educational use; follow local protocol.
Evidence
- TTM2 (2021) found no benefit of 33 °C over normothermia with active fever prevention.
- HYPERION (2019) suggested benefit for non-shockable rhythms; the ERC-ESICM 2025 guideline nevertheless recommends against routine active cooling and instead recommends fever prevention ≤ 37.5 °C for at least 72 h.
- AHA 2025 still allows a deliberate constant target between 32 and 37.5 °C for at least 36 h.
Controversies
- Whether subgroups (severe brain injury, non-shockable, in-hospital arrest) benefit from deeper hypothermia.
- Device-based vs simple methods: feedback devices achieve targets better but outcome benefit is unproven.
🇮🇳 India notes
- Most Indian ICUs do not have feedback cooling devices; ice packs, cooling blankets, cold room air, fans and scheduled paracetamol are practical. Accept "fever prevention" as the realistic standard.
- Ambient temperatures above 35 °C in summer make passive fever prevention harder; plan for active measures.
References
- 1
- 2
- 3
- 4
- 5
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

